PTC Therapeutics, Inc. (PTCT) Earnings History
Annual and quarterly earnings data from 2011 to 2025
Loading earnings history...
PTCT EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
PTCT Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 95.9% | 49.5% | 39.4% |
| 2024 | 92.9% | -37.5% | -45.0% |
| 2023 | 93.0% | -46.9% | -66.8% |
| 2022 | 93.6% | -64.0% | -80.0% |
| 2021 | 94.0% | -69.5% | -97.3% |
Download Data
Export PTCT earnings history in CSV or JSON format
Free sign-in required to download data
PTC Therapeutics, Inc. (PTCT) Earnings Overview
As of May 8, 2026, PTC Therapeutics, Inc. (PTCT) reported trailing twelve-month net income of -$187M, reflecting +264.5% year-over-year growth. The company earned $-2.26 per diluted share over the past four quarters, with a net profit margin of 39.4%.
Looking at the long-term picture, PTCT's historical earnings data spans multiple years. The company achieved its highest annual net income of $683M in fiscal 2025, representing a new all-time high.
PTC Therapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SRPT ($65M net income, -32.5% margin), BMRN ($269M net income, 10.8% margin), RARE (-$609M net income, -85.4% margin), PTCT has outperformed on profitability metrics. Compare PTCT vs SRPT →
PTCT Earnings vs Peers
Earnings metrics vs comparable public companies
PTCT Historical Earnings Data (2011–2025)
15 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $683M | +287.9% | $857M | $7.78 | 39.4% | 49.5% |
| 2024 | -$363M | +42.0% | -$303M | $-4.73 | -45.0% | -37.5% |
| 2023 | -$627M | -12.1% | -$440M | $-8.37 | -66.8% | -46.9% |
| 2022 | -$559M | -6.7% | -$447M | $-7.79 | -80.0% | -64.0% |
| 2021 | -$524M | -19.6% | -$374M | $-7.43 | -97.3% | -69.5% |
| 2020 | -$438M | -74.2% | -$432M | $-6.64 | -115.1% | -113.4% |
| 2019 | -$252M | -96.4% | -$241M | $-4.27 | -82.0% | -78.6% |
| 2018 | -$128M | -62.1% | -$116M | $-2.75 | -48.4% | -43.7% |
| 2017 | -$79M | +44.4% | -$64M | $-2.02 | -40.6% | -33.1% |
| 2016 | -$142M | +16.6% | -$132M | $-4.17 | -171.8% | -159.7% |
See PTCT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PTCT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PTCT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPTCT — Frequently Asked Questions
Quick answers to the most common questions about buying PTCT stock.
Is PTCT growing earnings?
PTCT EPS is $-2.26, with earnings growth accelerating to +264.5%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-187M.
What are PTCT's profit margins?
PTC Therapeutics, Inc. net margin is +39.4%, with operating margin at +49.5%. Above-average margins indicate pricing power.
How consistent are PTCT's earnings?
PTCT earnings data spans 2011-2025. The accelerating earnings trend is +264.5% YoY. Historical data enables comparison across business cycles.